IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Vaidya Sane Ayurved Laboratories IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Pune and caters to Healthcare - Ayurvedic sector. First Overseas Capital is the merchant banker of Vaidya Sane Ayurved Laboratories IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 8th December 2021.
Vaidya Sane Ayurved Laboratories IPO posted revenues of ₹ 63.14 crores and PAT of ₹ 2.70 crores in FY22 on annualised basis.
Revenue:
₹ 63.12 Cr.
EBITDA Margin:
8.27
% 
Net Worth: ₹ 11.12 Cr.
Market Capitalisation:
₹ 76.75 Cr.
P/E:
28.29 times
P/BV: 2.45 times
EV/EBITDA: 14.77 times
Financial results of Vaidya Sane Ayurved Laboratories IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-21 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 25.78 | 25.81 | 29.11 | 28.88 | |
| Net Worth | 11.12 | 9.77 | 8.22 | 8.78 | |
| Total Debt | 1.78 | 1.02 | 5.97 | 8.67 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
31.56
63.12 |
52.27 | 75.23 | 62.50 | |
EBITDA
EBITDA on annualised basis |
2.61
5.22 |
4.63 | 2.71 | 3.04 | |
PAT
PAT on annualised basis |
1.35
2.70 |
1.55 | -0.56 | 0.50 | |
Vaidya Sane Ayurved Laboratories IPO PAT Margin is 4.28 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Vaidya Sane Ayurved Laboratories IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-21 | FY21 | FY20 | FY19 |
|---|---|---|---|---|
| EBITDA Margin (%) | 8.27 | 8.86 | 3.60 | 4.86 |
| PAT Margin (%) | 4.28 | 2.97 | -0.74 | 0.80 |
| EPS (₹) | 1.94 | 2.22 | -0.80 | 0.71 |
| ROE (%) | 12.14 | 15.86 | -6.81 | 5.69 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 5.24 | 6.01 | -1.92 | 1.73 |
| Debt to Equity | 0.16 | 0.10 | 0.73 | 0.99 |
The market Capitalisation of Vaidya Sane Ayurved Laboratories IPO is ₹ 76.75 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Vaidya Sane Ayurved Laboratories IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Vaidya Sane Ayurved Laboratories IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Vaidya Sane Ayurved Laboratories IPO is ₹ 76.75 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Vaidya Sane Ayurved Laboratories IPO has a Price-to-Earnings (PE) ratio of 28.29 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Vaidya Sane Ayurved Laboratories IPO reported revenue of ₹ 63.14 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Vaidya Sane Ayurved Laboratories IPO provide insights into sales growth, market demand, and business scalability.
Vaidya Sane Ayurved Laboratories recorded an EBITDA of ₹ 5.22 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Vaidya Sane Ayurved Laboratories Profit After Tax (PAT) is ₹ 2.70 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 63.12 Cr.
EBITDA Margin:
8.27
%
Net Worth: ₹ 11.12 Cr.
Market Capitalisation:
₹ 76.75 Cr.
P/E:
28.29 times
P/BV: 2.45 times
EV/EBITDA: 14.77 times
Vaidya Sane Ayurved Laboratories operates in Healthcare - Ayurvedic and Health Care Provider. The Issue is listed on NSE EMERGE in Feb, 2022. Vaidya Sane Ayurved Laboratories IPO size was 20.23 with Issue price of 73.00 .
Merchant Banker(s) of Vaidya Sane Ayurved Laboratories IPO: First Overseas Capital Limited
Vaidya Sane Ayurved Laboratories IPO subscription was 2.82 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Vaidya Sane Ayurved Laboratories IPO listed at a listing price of 105.40 against the offer price of 73.00.
The current market price of Vaidya Sane Ayurved Laboratories is 125.00.
Why Us?
